Tumour Infiltrating Lymphocytes Adoptive Cell Therapy: Clinical Trials

1 trial of Tumour Infiltrating Lymphocytes Adoptive Cell Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Tumour Infiltrating Lymphocytes Adoptive Cell Therapy: new trials by email Literature Review of Tumour Infiltrating Lymphocytes Adoptive Cell Therapy trials Research Report on Tumour Infiltrating Lymphocytes Adoptive Cell Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma
Tumour Infiltrating Lymphocytes Adoptive Cell Therapy, Cyclophosphamide + Fludarabine Lymphodepletive Conditioning, Aldesleukin - Melanoma (Skin Cancer), Melanoma Metastatic
Phase 2Not yet recruitingEast Metropolitan Health Service, Australia102026-07-012026-06-16

Conditions studied

Melanoma (1)

Sponsors

East Metropolitan Health Service, Australia (1)

Countries

Australia (1)

Top investigators

Ben Carnley, MBBS (1)  ·  Peter Lau, MBBS (1)